Physician

Steven Jay Golombek, M.D.

According to 2025 Medicare claims, Steven Golombek, M.D. (NPI: 1760449565) practices rheumatology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is ALLERGY & ARTHRITIS ASSOCIATES (NPI: 1619015708; TIN: 223086057) and primary practice location at 07801-1630.

Golombek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,353 traditional Medicare patients, billed 483,311 HCPCS/CPT codes, and received $4,736,762 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 4,573 prescription claims across 703 beneficiaries totaling $1,372,151 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2020 DME data shows 12 claims. Open Payments data shows 76 records totaling $31,636. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,555,069 to $4,736,762. Similarly, Part D prescription costs have risen steadily, from $756,827 to $1,372,151. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,840 to $486.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$5.0M2015 Medicare payment: $2,555,069 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,855,890 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,417,228 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,341,276 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,041,774 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,869,436 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,735,773 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,841,780 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,440,766 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,736,762 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,068175,579$2,555,069
20161,150199,857$2,855,890
20171,043231,454$3,417,228
20181,443331,037$4,341,276
20191,395366,114$5,041,774
20201,292354,937$4,869,436
20211,340349,829$4,735,773
20221,370377,663$4,841,780
20231,444429,284$4,440,766
20241,353483,311$4,736,762

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$686K$1.4M2015 Drug cost: $756,827 (USD; Tot_Drug_Cst)2016 Drug cost: $648,033 (USD; Tot_Drug_Cst)2017 Drug cost: $841,346 (USD; Tot_Drug_Cst)2018 Drug cost: $919,030 (USD; Tot_Drug_Cst)2019 Drug cost: $847,058 (USD; Tot_Drug_Cst)2020 Drug cost: $951,039 (USD; Tot_Drug_Cst)2021 Drug cost: $864,922 (USD; Tot_Drug_Cst)2022 Drug cost: $1,137,126 (USD; Tot_Drug_Cst)2023 Drug cost: $1,294,345 (USD; Tot_Drug_Cst)2024 Drug cost: $1,372,151 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156434,420$756,827
20166444,267$648,033
20176574,649$841,346
20187114,710$919,030
20197084,827$847,058
20206994,606$951,039
20217024,669$864,922
20226664,404$1,137,126
20236514,519$1,294,345
20247034,573$1,372,151

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$184$3692015 Medicare payment: $310 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $369 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $140 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R15$310
2016N/R13$369
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R12$140
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more209209$171
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more9222,574$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5551,578$72
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle5142,455$64
J0897Injection, denosumab, 1 mg39640,500$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab321,272$268,726
EnbrelEtanercept25700$141,655
Xeljanz XrTofacitinib Citrate22660$127,163
SimponiGolimumab13390$85,900
ProliaDenosumab193,406$33,457

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.76$31,636Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steven Jay Golombek, M.D.?

Tedicare shows public-source Medicare data for Steven Jay Golombek, M.D. (NPI 1760449565), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Jay Golombek, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven Jay Golombek, M.D.?

Steven Jay Golombek, M.D. is linked to ALLERGY & ARTHRITIS ASSOCIATES (billing NPI 1619015708) in the available physician profile data.

Does Steven Jay Golombek, M.D. have Open Payments data?

Steven Jay Golombek, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.